Pharmafile Logo
Pharmafocus logo
Advanced Search
lynparza

Lynparza secures CHMP recommendation in first-line BRCA-mutated metastatic pancreatic cancer

June 1, 2020
Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza

Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has just secured recommendation for approval from the European Medicines …

News

US donates $1 billion to Oxford University’s COVID-19 vaccine in exchange for 300 million doses

June 1, 2020
Sales and Marketing COVID-19, coronavirus

The US has given $1 billion to AstraZeneca to advance the development and production of the vaccine they are creating …

News
shutterstock_243110086

First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment

May 29, 2020
Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir

The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …

News
trialy

Leukaemia drug nilotinib shows promise against Alzheimer’s in small clinical study

May 29, 2020
Medical Communications Alzheimer's, leukaemia

The leukemia drug nilotinib has shown promise in reducing the effects of Alzheimer’s disease and while having safe and minimal …

News
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

May 29, 2020
Medical Communications COVID-19, coronavirus, top 10

GlaxoSmithKline features prominently in the news this week, as they pledged to pay a cash bonus of £1,500 to staff …

News
shutter

MSD and Eisai announce meaningful objective response rates for Keytruda+Lenvima combo in two cancer patient populations

May 29, 2020
Medical Communications, Research and Development Lenvima, keytruda, pharma

MSD has pulled back the curtain on new data from two trials of its anti-PD-1 immunotherapy Keytruda (pemvbrolizmuab) in combination …

News
fda

FDA advises recall of diabetes drug metformin over carcinogen concerns

May 29, 2020
Medical Communications Carcinogens, MDMA

The FDA has asked that multiple pharmaceutical companies recall the formulations of their diabetes drug metformin after the regulatory body …

News
gsk_boronia_australia

GlaxoSmithKline commits to the production of one billion doses of COVID-19 vaccine adjuvant in 2021

May 28, 2020
Manufacturing and Production COVID-19, GSK, coronavirus, pharma, vaccines

GlaxoSmithKline has just come forward to commit to the manufacture and distribution of one billion doses of vaccine adjuvant against …

News

Novartis releases results of MS drug trials weeks ahead of FDA verdict

May 28, 2020
Business Services MS, Novartis

Novartis has revealed clinical trial data from testing its anti-CD20 leukameia drug Arzerra (ofatumumab) in patients with multiple sclerosis (MS). …

News
bmssyracuseny

BMS’ Zeposia becomes first S1P receptor modulator available in Europe for relapsing remitting multiple sclerosis

May 28, 2020
Sales and Marketing Avonex, Bristol-Myers Squibb, EU, Europe, Zeposia, bristol myers squibb, multiple sclerosis

Bristol Myers Squibb is celebrating after its oral therapy Zeposia (ozanimod), secured European Commission for the treatment of relapsing remitting …

News
black_market

European countries reject hydroxychloroquine treatments for COVID-19

May 28, 2020
Business Services COVID-19, coronavirus, hydroxychloroquine

Multiple European countries have rejected the use of hydroxychloroquine in patients suffering from coronavirus, due to a lack of evidence …

News
malaria_usa

FDA grants marketing approval for US Army’s malaria treatment

May 28, 2020
Business Services Malaria drug, US, US army, US., malaria

The FDA has granted marketing approval for the US Army Medical Research and Development Command’s (USAMRDC) Artesunate for injection, which …

News
martin_andrews

Evox appoints ex-GSK exec Martin Andrews as new non-Executive Director

May 28, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evox, GSK, appointment

Evox Therapeutics has named ex-GlaxoSmithKline executive Martin Andrews as its new non-Executive Director, it has emerged.   Andrews has previously …

Appointment
sergei_svarovsky

Axim Biotechnologies Inc announces Dr Sergei Svarovsky as Chief Scientific Officer of subsidiary Sapphire Biotech

May 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Axim Biotechnologies has announced that Dr Sergei Svarovsky will be the new Chief Scientific Officer of its subsidiary Sapphire Biotech. …

Appointment
fda

FDA approves Sanofi’s Dupixent for children with dermatitis

May 27, 2020
Research and Development Dupixent, Sanofi, atopic eczema

The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …

News
pharmafocus_june_2020_front_cover

The June 2020 issue of Pharmafocus is available to read free online now!

May 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access

The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …

News
cdc_coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

May 27, 2020
Research and Development COVID-19, coronavirus, coronavirus round up

COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …

News

NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer

May 27, 2020
Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq

NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …

News
nhsssssss

Remdesivir available to select COVID-19 patients through the NHS

May 27, 2020
Research and Development coronavirus, covid19

Gilead Sciences Ebola drug remdesivir will be available for selected patients who are suffering from coronavirus through the NHS. The …

News
darren_taylor1

Living with multiple ‘invisible’ conditions

May 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026